A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies
NCT00820768
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
ABI-010
Sponsor
Celgene